- Article metrics
- Last updated: Mon, 13 Oct 2025 10:54:36 Z
Retraction Note: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis
Access & Citations
-
- 643
- Article Accesses
-
- 0
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.